Vaxart Inc. (NASDAQ: VXRT) stock jumped 1.03% on Monday to $0.72 against a previous-day closing price of $0.71. With 0.71 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.59 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.7400 whereas the lowest price it dropped to was $0.7100. The 52-week range on VXRT shows that it touched its highest point at $2.73 and its lowest point at $0.56 during that stretch. It currently has a 1-year price target of $4.50. Beta for the stock currently stands at 0.66.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VXRT was down-trending over the past week, with a drop of -9.21%, but this was up by 3.04% over a month. Three-month performance dropped to -25.03% while six-month performance fell -7.84%. The stock lost -74.06% in the past year, while it has lost -25.49% so far this year. A look at the trailing 12-month EPS for VXRT yields -0.76 with Next year EPS estimates of -0.55. For the next quarter, that number is -0.18. This implies an EPS growth rate of -45.50% for this year and 16.70% for next year.
Float and Shares Shorts:
At present, 151.97 million VXRT shares are outstanding with a float of 150.71 million shares on hand for trading. On Aug 30, 2023, short shares totaled 16.47 million, which was 10.84% higher than short shares on Jul 30, 2023. In addition to Mr. Cezar Andrei Floroiu M.B.A. as the firm’s CEO, Pres & Director, Dr. Sean N. Tucker Ph.D. serves as its Sr. VP & Chief Scientific Officer.
Through their ownership of 22.69% of VXRT’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, VXRT reported revenue of $0.00 and operating income of -$29.25M. The EBITDA in the recently reported quarter was -$27.87M and diluted EPS was -$0.23.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VXRT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With VXRT analysts setting a high price target of $8.00 and a low target of $1.50, the average target price over the next 12 months is $4.50. Based on these targets, VXRT could surge 1011.11% to reach the target high and rise by 108.33% to reach the target low. Reaching the average price target will result in a growth of 525.0% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded VXRT stock several times over the past three months with 5 Buys and 0 Sells. In these transactions, 36,422 shares were bought while 0 shares were sold. The number of buy transactions has increased to 22 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 1,188,172 while 0 shares were sold.